Antithrombotic Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes: Recommendations of the Rio de la Plata Expert Panel

Author：

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.19, Iss.6, 2000-06, pp. : 409-420

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacologic Therapy for Non ST-segment Elevation Acute Coronary Syndromes: Focus on Antithrombotic Therapy

By Danchin Nicolas Aïssaoui Nadia

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 325-330

Springer Publishing Company

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary Syndromes: Estimating the Economic Implications

By Hillegass W.B.

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 41-55

Adis International

Access to resources Recommend Favorite

Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome

By McKeage Kate Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 687-698

Adis International

Access to resources Recommend Favorite

Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes

By Galla John M Mahaffey Kenneth W

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1241-1251

Informa Healthcare

Access to resources Recommend Favorite

Antithrombotic therapy in ST-segment elevation myocardial infarction

By Wong Cheuk-Kit White Harvey D

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 213-223

Informa Healthcare

Access to resources Recommend Favorite